Respiro boosts adherence to asthma therapy and health outcomes
Brussels/Milan, BE/IT, 6 May 2019 – The international community is preparing to celebrate World Asthma Day, tomorrow. Asthma is a disease which affects over 300 million people worldwide, a number that is set to rise to 400 million by 2025. Each year, millions of...
Respiro wins open call for innovation of Germany’s KBV
London/Berlin, UK/DE, 1 October 2018 – Amiko announces that its flagship Respiro platform has won the open call for innovation of the German National Association of Statutory Health Insurance Physicians (KBV). Respiro, a digital medicine offering that uses advanced...
Amiko among top three German digital health companies in 2018
London/Berlin, UK/DE, 25 September 2018 – The Heath-I initiative by Handelsblatt and Germany’s largest public health insurance, the Techniker-Krankenkasse nominated Amiko Digital Health for this year’s Health-I Award among the top three companies that have the...
Amiko and Luz Saúde Partner to Upgrade Respiratory Care
London/Lisbon, UK/PT, 03 July 2018 – Amiko Digital Health Limited (Amiko), a company that develops advanced medication sensor technologies and digital therapeutic solutions
Amiko and Sanner announce strategic partnership
Sanner and Amiko partner to develop digital solutions for true medication adherence Bensheim/Germany, London/UK, 13 February 2018 – How can artificial intelligence, drug
